Assessment of serum Retinol-Binding Protein-4 Levels in patients with acute exacerbation of chronic obstructive disease at intensive care unit
Conclusion Serum-Retinol-Binding Protein-4 can be used as a predictive biomarker for mortality in AECOPD. We recommend that the serum RBP4 should be taken in consideration as a part of the assessment of mortality of AECOPD patients admitted in ICU.
Source: Egyptian Journal of Chest Diseases and Tuberculosis - Category: Respiratory Medicine Source Type: research
More News: Bilirubin | Chronic Obstructive Pulmonary | Egypt Health | Intensive Care | Liver | Study | Tuberculosis | Urology & Nephrology | Vitamin A